Published by: Springer
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Immunology | 230 | 9 | 9 | 4 |
| Medicine | 1562 | 60 | 55 | 16 |
The journal mostly deals with topics like Internal medicine, Hematology, Cancer research, Oncology and Immunology. It focuses on Internal medicine but the discussions also offer insight into other areas such as Gastroenterology and Pathology. Experimental hematology & oncology addresses concerns in Hematology which are intertwined with other disciplines, such as Adverse effect, Lymphoma, Leukemia, Bone marrow and Multiple myeloma.
The main emphasis of the journal is the subject of Lymphoma, focusing on Diffuse large B-cell lymphoma. Bioinformatics, Carcinogenesis, Cancer cell, Tumor microenvironment and Stem cell are some topics wherein Cancer research research discussed in Experimental hematology & oncology have an impact. Discussions in the journal are anchored in the subject of Stem cell and the similar topic of Transplantation.
Issues in Oncology were discussed, taking into consideration concepts from other disciplines like Hematopoietic stem cell transplantation, Clinical trial, Regimen, Breast cancer and Pharmacology. Research on Immunology presented in it focuses, in particular, on Immune system, T cell, B cell, Antibody and Cytokine. The majority of Immune system studies in Experimental hematology & oncology are focused on the subject of Immunotherapy.
The most cited publications cover a variety of subjects, including Internal medicine, Hematology, Immunology, Cancer research and Oncology. Issues in Internal medicine were discussed in the journal papers, taking into consideration concepts from other disciplines like Gastroenterology, Pharmacology and Pathology. The journal papers address concerns in Hematology which are intertwined with other disciplines, such as Chemotherapy, Myeloid, Myeloid leukemia, Gene and Leukemia.
Experimental hematology & oncology is mainly concerned with subjects like Internal medicine, Cancer research, Hematology, Oncology and Lymphoma. The study on Internal medicine presented in Experimental hematology & oncology intersects with the topics under Gastroenterology. The work on Cancer research tackled in Experimental hematology & oncology brings together disciplines like Cancer cell, Cancer, microRNA and Immune system.
Experimental hematology & oncology focuses on Hematology research as part of the broader topic of Immunology. The research on Oncology tackled can also make contributions to studies in the areas of Stage (cooking), Colorectal cancer and Immunotherapy. Lymphoma research featured in it incorporates concerns from various other topics such as T cell and Activator (genetics).
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Experimental hematology & oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Experimental hematology & oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 4.26% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.44% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.89% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.44% of all publications and 42.22% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
José Luis Piñana;José Luis Piñana;Rodrigo Martino;Irene García-García;Rocío Parody
(2020)Mohammad Keykhaei;Masood Masinaei;Esmaeil Mohammadi;Sina Azadnajafabad
(2021)Huijun Huang;Wenjun Zhang;Wenyu Cai;Jinqin Liu
(2021)Shi-Zhe Zhang;Shi-Zhe Zhang;Xiao-Dong Zhu;Xiao-Dong Zhu;Long-Hai Feng;Long-Hai Feng;Xiao-Long Li;Xiao-Long Li
(2021)Lun-Xi Peng;Lun-Xi Peng;Guang-Ling Jie;Guang-Ling Jie;An-Na Li;Si-Yang Liu
(2021)For those interested in expanding their medical careers, exploring related online degrees can open up numerous opportunities. Many nurses looking to advance can benefit from online bsn to msn programs that offer affordable paths to higher qualifications without sacrificing flexibility.
Additionally, registered nurses aiming to earn their bachelor's degree might find rn to bsn no clinicals programs highly appealing. These options eliminate the need for on-site clinical hours, making it easier to balance work and study.
For advanced practice, a Doctor of Nursing Practice can be completed efficiently through a 12 month dnp program online, providing accelerated paths for professionals seeking leadership roles in healthcare.
Meanwhile, those new to the medical field might consider becoming a medical assistant through medical assistant programs. These accelerated courses often take as little as six weeks, offering quick entry into clinical support roles.
